Evidence map›Paper›PMID 39753943›Full record

ArticleJournal of assisted reproduction and genetics2025

Duration of cryostorage is not associated with rates of thaw survival, fertilization, blastulation and ploidy, or pregnancy outcomes of vitrified human oocytes.

Sarah Roger, Samantha Estevez, Carlos Hernandez-Nieto, Shawn Kripalani, Atoosa Ghofranian, Morgan Baird, Joseph Lee, Richard Slifkin, Christine Briton-Jones, Alan Copperman and 1 more

Abstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah RogerIcahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. sarah.c.roger@gmail.com.ORCID http://orcid.org/0009-0004-7714-8430
Samantha EstevezIcahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Carlos Hernandez-NietoReproductive Medicine Associates of New York, New York, NY, USA.
Shawn KripalaniIcahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Atoosa GhofranianIcahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Morgan BairdReproductive Medicine Associates of New York, New York, NY, USA.
Joseph LeeReproductive Medicine Associates of New York, New York, NY, USA.
Richard SlifkinReproductive Medicine Associates of New York, New York, NY, USA.
Christine Briton-JonesReproductive Medicine Associates of New York, New York, NY, USA.
Alan CoppermanIcahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Rachel DanisIcahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study is to evaluate duration of oocyte cryostorage and association with thaw survival, fertilization, blastulation, ploidy rates, and pregnancy outcomes in patients seeking fertility preservation.

methodsRetrospective cohort study to evaluate clinical outcomes in patients who underwent fertility preservation from 2011 to 2023 via oocyte vitrification for non-oncologic indications. Primary outcome was thaw survival rate. Secondary outcomes included rates of fertilization, blastulation and embryo ploidy, as well asn pregnancy outcomes. Demographic, controlled ovarian stimulation, and laboratory data were collected for each patient. Analyses were conducted using Kruskal-Wallis, Fisher's exact test, or Chi-squared test, as appropriate. A multivariate logistic regression analysis was utilized, and adjusted odds ratios with 95% confidence intervals were calculated using Group A as the reference group.

resultsA total of 5995 oocytes met inclusion criteria. These were divided into quartiles based on duration of cryostorage. Group A included oocytes in cryostorage for 0-2 years; Group B, 3-5 years; and Group C, 6-11 years. Significant differences were found when comparing thaw survival (p < 0.0001), fertilization (p = 0.0009), and blastulation rates (p = 0.0002) among groups; however, no significant differences were seen after multivariate GEE regression analysis. No significant differences were seen in rates of euploidy (p = 0.70), live birth (p = 0.81), and clinical pregnancy (p = 0.58) among groups. After analyzing years in cryostorage as a continuous variable and controlling for confounders, duration of cryostorage was not related to odds of thaw, fertilization, blastulation, euploid rates, or pregnancy outcomes.

conclusionLength of time in cryostorage is not associated with compromised rates of oocyte thaw survival, fertilization, blastulation, ploidy, or pregnancy outcomes.

Indexed as

CryopreservationFertility PreservationOocytesAdultFemaleFertilizationFertilization in VitroHumansOvulation InductionPloidiesPregnancyPregnancy OutcomePregnancy RateRetrospective StudiesVitrificationBlastulation rateOocyte cryopreservationPloidy ratePregnancy outcomesThaw survival. Fertilization rate

Identifiers

PMID39753943
PMCPMC11871184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.